Posts Tagged ‘MoleSafe’

Melanoma News and Reviews – Ipi and “The Big C”

Friday, August 20th, 2010

Just watched the premiere of Showtime’s new hit, “The Big C,” in which Laura Linney plays a woman newly diagnosed with Stage Four Melanoma. The plot revolves around her decision to “carpe diem” and forgo traditional therapies to live out her anticipated remaining year joyfully and sometimes frivolously. As the show’s writer says,

“in many ways, this series is not about cancer per se.  It’s about living the life we want to live and not wasting our precious time!”

“Seizing the day” can be a good prescription for any human being, and I encourage it wholeheartedly (though not as foolhardily, perhaps, as she does, when she knocks down her porch and shade tree to spontaneously add a swimming pool to her small front yard!)  However, I would remind viewers that while the most serious and often most aggressive form of skin cancers, melanoma can be treatable and when caught early especially with proper screenings does not have to be a death sentence.

Aside from that, it is good to see the disease brought to light.  While there is not much apparent sidebar content or instructive information about melanoma on Showtime’s site, there is an alliance with the American Cancer Society that promises donations in exchange for viewing a clip of the show…a good approach to raise awareness of the show, for sure, but also for our passion: raising awareness about melanoma.

View Big C trailer to have $1 Donated, thanks to Showtime and American Cancer Society

View Big C trailer to have $1 Donated, thanks to Showtime and American Cancer Society

And here’s a link to the Big C Facebook page in case you want to participate there (to be sent right to that page be sure you’re logged in on Facebook) and weigh in.  Oddly, though, neither that Facebook page or the Showtime page for the show itself seem to provide any links to the More Birthdays Facebook page which they are supporting.  That is a lost opportunity to drive more donations and align themselves deeper with the cause.  Clearly, this is a “comedy that plays with dark and light tones.”  And entertainment sells, but there is always more room for responsible education, even if via links from their site.

In terms of Cathy’s life expectancy, as depicted on the show, it is, unfortunately fairly accurate:  The typical survival rate for patients with metastatic melanoma is six to nine months.  However, the new drug you may have read about here in June and elsewhere is continuing to show some promise in extended life expectancy, if slowly:

Metastatic melanoma patients who took the drug demonstrated a median survival rate of 10 months, a 3.6 month improvement over those who did not take the medication.

No one is laughing about the seriousness of melanoma.  But we all must just keep trying to find the joy, if even through television escapes.

  • Share/Bookmark

Optimizing Skin Cancer Awareness

Monday, August 16th, 2010

It’s interesting to see how intuitive search engines can be in today’s high-tech digital society.  While MoleSafe tries to take the “be proactive, smart and aware” but optimistic stance about the real issues of skin cancer and melanoma, one ad served up recently on a skin cancer blog created a decidedly more dire tone. Coincidentally, an ad for Life Insurance policies appeared adjacent to a post about sun exposure and protection.

Optimizing Preparedness?

Optimizing Preparedness?

Truth be told, the blog, written by Jennifer Amundsen, is well-written and informative, and the other ads that rotate in do reflect other issues. I just happened to catch it with a somber underscore.  So, yes, be sure your life insurance policy is up to date, but if you practice sun safety and regular screenings and mole-mapping we hope you won’t need it for a long, long time.

  • Share/Bookmark

More MoleSafe in the News

Sunday, August 1st, 2010

We’re always appreciative of news stories on MoleSafe — such as this one in today’s Asbury Park Press which mentions the use of our system now at CentraState Healthcare in Freehold, NJ.  What’s terrific is the inclusion of informative facts about skin cancer and reminders about the need for better screenings. Press like this raises everyone’s awareness about early diagnosis and includes a good overview of our process:

For sun worshipers worried about the damage they may have wreaked on their skin, the CentraState Healthcare System has introduced a new screening and surveillance system aimed at improving early detection of melanoma.

The system, known as MoleSafe, combines physical skin examinations with full-body photography and dermoscopy, which allows physicians to take a microscopic look at skin lesions.

CentraState in Freehold Township is the first hospital in the state to offer the program. There are five additional MoleSafe clinics around the country, including one in Millburn.

So please forward to your friends and loved ones, tweet, post and email away!

Thank you.

  • Share/Bookmark

MoleSafe’s Melanoma Screening Is Newsworthy

Monday, July 12th, 2010

We are very excited by the excellent overview Dr. Max Gomez and WCBS-TV in New York provided on the latest in skin cancer screenings, and in particular the MoleSafe method.  If you’re not an early bird or not in the metro area and missed the segment on the morning news this week, here’s a link so you can view it again.  You can also read a transcript of the news story for more details.

Maddie-CBStv

While getting your picture taken in a hospital gown is not most people's idea of a flattering photo shoot, especially when it includes unusual poses, but it could be a life saver.

If you’ve been reading this blog, you may also have recognized our own Maddie Pallamary, RN, from the MoleSafe Millburn location, who conducted the patient examination.  I’m very proud of the calming, professional and informative style that Maddie clearly exhibits, as do all of our staff clinicians and physicians around the country, and which is so reassuring to new patients.

It is truly exciting to have such an esteemed institution as NYU Langone Medical Center as MoleSafe’s first U.S. hospital partner. But whether it is there in New York City, or Albuquerque, Savannah…or any of our now 6 locations, please consider getting this potentially lifesaving screening for you and your loved ones.

We truly hope future news coverage about Melanoma will be about its decline vs our ongoing battle to raise awareness and skin cancer prevention.

  • Share/Bookmark

The View Offers a Better Outlook for Melanoma Screenings

Tuesday, July 6th, 2010

The NYU Post-Graduate Medical School and the highly esteemed Ronald O. Perelman Department of Dermatology, which is the first U.S. hospital to have embraced the MoleSafe method, hosted Advances in Dermatology last month for dermatologists and dermatologic surgeons and residents.  The goal of the 2-day symposium was to feature findings and lectures with an “unbiased and provocative perspective.”  For that reason, I’m particularly proud that the MoleSafe protocol and our revolutionary “View Software” was included in a morning dedicated to information on melanoma and advances in early detection.

The Right View

“View” lets physicians examine images WHILE the patient is in the office for an exam, which enables not only a more thorough exam by the doctor, but more information back to patients in real-time. [Read more in my post from November, when View was unveiled at the International Dermoscopy Society Conference.]

Previously, even with a dermatoscope, doctors reviewed only a few moles and could never be fully confident that their naked eye scrutiny discerned some of the finer, or questionable moles. For dermatologists who refer patients to MoleSafe for a comprehensive and state-of-the-art screening, this software is available for use in their offices at no charge. We just feel it is imperative to bring the opportunity for the best options for melanoma detection to as many patients as possible…and View enables a more clear, super enlarged view of all moles for doctor review, with the ability to pause on any questionable areas and compare the patient’s actual skin along side the macro images that have been delivered to the screen.

Based on the feedback we’ve gotten, this looks to be revolutionizing doctor/patient relationships and the very process of screening for  earlier detection of melanomas, especially among high risk patients.

We encourage all of our readers to review the MoleSafe web site FAQs, and to take advantage of the increasing ways and places to get the most efficacious skin cancer examination… and help us make early, accurate detection a team effort among patients, their doctors, and technology.

  • Share/Bookmark

More exciting news from MoleSafe

Thursday, July 1st, 2010

UPDATE: New Yorkers, set your DVR and Don’t Miss MoleSafe with Dr. Max Gomez

This Thursday (new date), 7/8, at 5:45A and 6:45A hours, please look for my interview with Dr. Max Gomez on WCBS-TV (channel 2), when we’ll discuss advances in melanoma detection and our new clinic at  NYU LANGONE MEDICAL CENTER, the first Hospital in the United States to offer MoleSafe’s cutting-edge Melanoma detection service.

New Jersey MoleSafe associate appointed Chairman of Governor’s Cancer Prevention Task Force

As noted in the Asbury Park Press, our own Dr. Jarrod Kaufman, a surgeon on staff at CentraState Medical Center in Freehold Township which recently added the MoleSafe program to their screening services, has been appointed New Jersey chairman of the American College of Surgeons Commission on Cancer (CoC) Cancer Liaison Program. He is also the chairman of the melanoma work group of the New Jersey Governor’s Task Force on Cancer Prevention, Early Detection and Treatment. We are proud such an esteemed physician is a proponent of our screening services.

Oh – and one more note:  MoleSafe is proud to welcome not only CentraState Medical Center to our family of MoleSafe screening locations, but now Nancy N. and J. C. Lewis Cancer & Research Pavilion at St. Joseph’s/Candler in Savannah, GA as well.  Check out all of our locations and get an appointment to get checked out today.

Tanning and Taxes

Cancer prevention is a timely topic with the big summer holiday upon us.  But it’s not just sun-protection while having outdoor fun that is getting press. CBS Evening News was one of many covering the new 10% sales tax that kicked in today on tanning salons.  See the full story here at the 13:35 mark.

Have a fun and sun-smart holiday weekend!

  • Share/Bookmark

To Top it Off…

Monday, June 21st, 2010

It was heartening to see a steady stream of people purchasing hats at one of the street fairs in New York City this weekend.  I hope it was an enjoyable Father’s Day weekend for you, and that perhaps many of you bought dad a life-preserving HAT for sun protection in lieu of a tie?

To Top it Off: Sun Safety

To Top it Off: Sun Safety

FYI, at these fairs it’s easy to negotiate for a discount if you buy more than one, so consider a hat for yourself, too!

Another good thing to do for yourself and a loved one is to have regular  skin cancer screenings.

What topped off my weekend though was  also the opportunity to share this story about digital dermoscopy and MoleSafe’s thorough melanoma screenings, thanks to recent press on AssociatedContent.com.   Please share this info with all your friends and relatives as we enter into the season of “fun in the sun.”

Just don’t forget your hat.

  • Share/Bookmark

What’s in a name? If it’s “ipi,” a lot!

Friday, June 11th, 2010

What’s in a name?  If it’s ipilimumab – or “ipi” for short – it may be the first name associated with prolonged life expectancy for melanoma victims.  This new immune stimulator has been making headlines recently for its early success in increasing stage four melanoma survival rates for up to four months. While that might not sounds like a lot, it’s considered highly significant. Dr. Steven O’Day of the Angeles Clinic and Research Institute in Santa Monica, Calif., a lead investigator in the recent melanoma trial explains,

This important because this is a disease where the average survival in these patients is six to nine months, so to increase on average the survival by an additional four months is a very large difference.

And though as Dr. Charles M. Balch, a melanoma expert at Johns Hopkins, said the results of the recent clinical trials are “a single, not a home run,” he added that for this disease, which impacts almost 70,000 Americans a year and growing, “even a single was important”.  As further described in The New York Times coverage of ipi,

In a study of patients who had advanced melanoma, those who got an experimental drug lived a median of about 10 months, compared with 6.4 months for those in a control group. After two years, about 23 percent of those who got the drug were alive, compared with 14 percent in the control group.

Lung cancer and melanoma are among the hardest cancers to treat. So the studies are being viewed as significant advances, though far from cures.

Dr. O’Day, who presented the research at this month’s ASCO conference, said no prior large randomized trial in melanoma has been able to demonstrate an improved survival in this type of cancer at all.  ascocover

He calls ipilimumab “the light at the end of a long, dark tunnel.”

“These results are exciting because patients with melanoma have few treatment options,” Dr. O’Day said. “After 30 years of failed studies, we finally have an option that shows a significant increase in overall survival, an endpoint that many oncology studies strive for. This new class of inhibitors that overcome T-cell suppression offers hope to melanoma patients and oncologists alike.”

The NY Times article provides a good explanation of how T-cell suppression works to possibly slow tumor growth rate though without yet being able to “put the brakes on”:

Ipilimumab is a more general immune booster. It blocks a protein called CTLA-4 that acts as a brake on T cells, the soldiers of the immune system. It is already also being tested against lung and prostate cancer.

Still, if a tumor does not elicit a strong immune response to begin with, then just keeping the response going longer would not help much, just as lifting one’s foot from the brake usually will not make a car go faster if the accelerator is not pressed.

We at MoleSafe are heartened by this news.  As always, we encourage regular and thorough screenings to provide the best line of first defense in preventing melanoma from reaching crisis status.  Please contact us at any of our now 6 clinical screening locations.

  • Share/Bookmark

Discussing advances in Detecting Melanoma – On Fox News

Thursday, June 3rd, 2010

I was recently invited to discuss advances in Melanoma detection on the Fox Strategy Room.  I hope you’ll take a look at this video and learn about the strides we’re making at MoleSafe.

Dr. Richard Bezozo on Fox Strategy Room 5/28/10

Dr. Richard Bezozo on Fox Strategy Room 5/28/10

  • Share/Bookmark

Melanoma Awareness Month!

Monday, May 3rd, 2010

May is Melanoma Awareness Month. So, we thought it was a good time to offer the following reminders about this disease that kills one American every hour.   The first is to remember that if detected early, melanoma can often be successfully treated.

What are the best ways to stay on top of it? Well, of course awareness is the first step.  Understanding the serious nature of this form of skin cancer will drive more people to practice better sun safety, and get regular skin exams.  2010 is also the 25th-year anniversary of the development of the “ABCDEs” – the acronym for the quick and simple criteria to use for skin self-exams to help detect skin cancers, including melanoma. Please share these easy reminders with your friends and loved ones:

A is for Asymmetry where one-half of the mole is unlike the other.

ADD's Downloadable Mole Map Guide

B is for Border where the mole is irregular, scalloped or poorly defined.

C is for Color that varies from one area to another or has different shades of tan, brown, black and sometimes white, red or blue.
D is for Diameter of a mole when it is bigger than the size of a pencil eraser.
E is for Evolving or changing in size, shape or color.

The ABDCEs were created by dermatologists at NYU Langone Medical Center, which is home to the most recent addition of the MoleSafe clinic locations.  This exemplary institution is also conducting its annual free skin cancer screening on Thursday, May 6, 2010 from 1:30 PM to 5:00 PM at 550 First Avenue in the Charles C. Harris Skin and Cancer Pavilion on the first floor of the Medical Center. No appointment is necessary for the free screening and everyone is encouraged to take advantage of this annual opportunity – especially those who have a changing mole, a history of melanoma, or who are over the age of 50 and do not have a regular dermatologist.

Also, the Skin Cancer Foundation is back on the road, conducting free screenings around the country. For a list of a locations please visit their web site.

As always, we encourage you to invest in your healthy future with the “gold standard” of skin cancer screenings at any of our four (soon to be SIX!) MoleSafe locations in the country.  Our final reminder?  Melanoma Awareness shouldn’t be limited to the month of May.  Stay vigilant.  Stay aware.

  • Share/Bookmark